Kevin Petrecca, MD, PhD, FRCS(C)
Associate Professor
Associate Chair -聽Neurosurgery, Department of Neurology and Neurosurgery聽
Chief of聽Neurosurgery, 平特五不中 Health Centre
Kevin Petrecca's聽clinical practice is dedicated to treating brain cancer patients and his research program focuses on 1) studying the origin, development, and properties of brain cancer stem cells and 2) developing new tools for brain cancer surgery.
Raman spectroscopy detects distant invasive brain cancer cells centimeters beyond MRI capability in humans. Jermyn M, Desroches J, Mercier J, St-Arnaud K, Guiot MC, Leblond F, Petrecca K. Biomedical Optics Express. 2016;7:5129-5137.
A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma. Shenouda G, Souhami L, Petrecca K, Owen S, Panet-Raymond V, Guiot MC, Corredor AG, Abdulkarim B. International Journal of Radiation Oncology, Biology, Physics. 201797:487-494.
Intraoperative brain cancer detection with Raman spectroscopy in humans.聽Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, Bernstein L, Guiot MC, Petrecca K, Leblond F. Science Translational Medicine. 2015;7:274.
DRR regulates AKT activation to drive brain cancer invasion. Dudley A, Sater M, Le PU, Trinh G, Sadr MS, Bergeron J, Deleavey GF, Bedell B, Damha MJ, Petrecca K. Oncogene. 2014;33:4952-60.
DRR drives brain cancer invasion by regulating cytoskeletal-focal adhesion dynamics. Le PU, Angers-Loustau A, de Oliveira RM, Ajlan A, Brassard CL, Dudley A, Brent H, Siu V, Trinh G, M枚lenkamp G, Wang J, Seyed Sadr M, Bedell B, Del Maestro RF, Petrecca K. Oncogene. 2010;29:4636-4